Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center

Gastroenterology

Volumn 140, Issue 7, 2011, Pages 1980-1989

  Hoeroldt, Barbara ^b   McFarlane, Elaine ^a   Dube, Asha ^a   Basumani, Pandurangan ^b   Karajeh, Mohammed ^a   Campbell, Michael J ^c   Gleeson, Dermot ^a,d  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Autoimmune Disease; Immunosuppressive Therapy; PBC; Prednisolone

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CORTICOSTEROID; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISOLONE;

ADDISON DISEASE; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER DISEASE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; CAUSE OF DEATH; CHILD; COMORBIDITY; CONTROLLED STUDY; DEATH; DECOMPENSATED LIVER CIRRHOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; NONTRANSPLANT CENTER; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SCHOOL CHILD; SEX RATIO; STANDARDIZED MORTALITY RATIO; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; UNSPECIFIED SIDE EFFECT;

EID: 79958162463     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.02.065     Document Type: Article

References (32)

1. F. Alvarez, P.A. Berg, and F.B. Bianchi International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 962
2. R.D. Soloway, W.H.J. Summerskill, and A.H. Baggenstoss Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis Gastroenterology 63 1972 820 833
3. S.K. Roberts, T.M. Therneau, and A.J. Czaja Prognosis of histological cirrhosis in type 1 AIH Gastroenterology 110 1996 848 857 (Pubitemid 26071852)
4. S. Kanzler, H. Lhr, and G. Gerken Longterm management and prognosis of autoimmune hepatitis (AIH): a single center experience Z Gastroenterol 39 2001 339 348 (Pubitemid 32494319)
5. J.J. Feld, H. Dinh, and T. Arenovich Autoimmune hepatitis: effects of symptoms and cirrhosis on natural history and outcome Hepatology 42 2005 53 62 (Pubitemid 40911311)
6. T. Al-Chalabi, J.A. Underhill, and B.C. Portmann Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis J Hepatol 48 2008 140 147 (Pubitemid 350191991)
7. P. Muratori, A. Granito, and C. Quarneti Autoimmune hepatitis in Italy: the Bologna experience J Hepatol 50 2009 1210 1218
8. A.J. Czaja, N. Menon, and H.A. Carpenter Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis Hepatology 35 2002 890 897 (Pubitemid 34258384)
9. A.J. Czaja, and H.A. Carpenter Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly Hepatology 43 2006 532 538
10. A. Montano-Loza, H.A. Carpenter, and A.J. Czaja Consequences of treatment withdrawal in type 1 autoimmune hepatitis Liver Int 27 2007 507 515 (Pubitemid 46534573)
11. S. Verma, B. Gunuwan, and M. Mendler Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission, and plasma cell activity in the liver biopsy Am J Gastroenterol 99 2004 1510 1516 (Pubitemid 39180099)
12. S. Seela, H. Sheela, and J.L. Boyer Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy Liver Int 25 2005 734 739 (Pubitemid 41038654)
13. Y. Miyaki, Y. Iwasaki, and R. Tereda Persistent normalisation of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis J Hepatol 43 2005 951 957 (Pubitemid 41627979)
14. T. Al-Chalabi, J.A. Underhill, and B.C. Portmann Effects of serum aspartate aminotransferase levels in patients with autoimmune hepatitis influence disease course and outcome Clin Gastroenterol Hepatol 6 2008 1389 1395
15. J. Keating, C.J. O'Brien, and A.J. Stellon Influence of aetiology, clinical and histological features on survival in chronic active hepatitis: an analysis of 204 patients Q J Med 62 1987 59 66 (Pubitemid 17015916)
16. S. Verma, M. Torbenson, and P.J. Thulvath The impact of ethnicity on the natural history of autoimmune hepatitis Hepatology 46 2007 1828 1835
17. J. Kogan, R. Safadi, and Y. Ashur Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients J Clin Gastroenterol 35 2002 75 81 (Pubitemid 34663355)
18. A. Montano-Loza, H.A. Carpenter, and A.J. Czaja Features associated with treatment failure in type 1 AIH and predictive value of the model of end-stage liver disease Hepatology 46 2007 1138 1145 (Pubitemid 350144778)
19. T. Hino, R. Kumashiro, and T. Ide Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan Int J Mol Med 11 2003 749 755
20. A.J. Montano-Loza, H.A. Carpenter, and A.J. Czaja Improving the endpoint of corticosteroid therapy in type I autoimmune hepatitis to reduce the frequency of relapse Am J Gastroenterol 102 2007 1005 1012 (Pubitemid 46698236)
21. K. Ishak, A. Baptista, and L. Bianchi Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
22. Office for National Statistics Mortality data and cause-specific mortality http://www.statistics.gov.uk/hub/health-social-care/index.html Accessed December 29, 2010
23. T. Al-Chalabi, J.A. Underhill, and B.C. Portmann Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre J Hepatol 45 2006 575 583 (Pubitemid 44307378)
24. C. Schramm, S. Kanzler, and K.H. Meyer zum Bschenfelde Autoimmune hepatitis in the elderly Am J Gastroenterol 96 2001 1587 1591 (Pubitemid 32455095)
25. D.R. Parker, and J.G.C. Kingham Type 1 autoimmune hepatitis is primarily a disease of later life Q J Med 90 1997 289 296 (Pubitemid 27180005)
26. L.O. Poulsen, A.M. Thulstrup, and L. Mellemkjaer Mortality and causes of death in patients with "lupoid hepatitis." A long-term follow-up study in Denmark Dan Med Bull 49 2002 263 265
27. H.T. Sorensen, A.M. Thulstrup, and L. Mellenkjaer Longterm survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark J Clin Epidemiol 56 2003 88 93 (Pubitemid 36183320)
28. K.M. Boberg Prevalence and epidemiology of autoimmune hepatitis Clin Liver Dis 6 2002 347 359
29. S. Ritland The incidence of chronic active hepatitis in Norway Scand J Gastroenterol 20 Suppl 107 1985 58 60 (Pubitemid 15142060)
30. B. Hoeroldt, N. Farquharson, and K. Shepherd Cancer in autoimmune hepatitis Gut 57 Suppl I 2008 A79
31. M. Werner, S. Almer, and H. Prytz Hepatic and extrahepatic malignancies in autoimmune hepatitis A long-term follow-up in 473 Swedish patients J Hepatol 50 2009 388 393
32. M.F. Yuen, H.J. Yuan, and D.K. Wong Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications Gut 54 2005 1610 1614 (Pubitemid 41531781)